IntraSight

Interventional applications platform

The IntraSight applications platform is where imaging, physiology, co-registration* and software all come together to clearly identify coronary and peripheral artery disease, and allow for more optimized treatment plans. IntraSight is built on a new foundational platform designed to meet the evolving needs of your lab today and tomorrow.

Contact us

Request contact
How can we help you?

*

Contact information

* This field is mandatory

1 Contact details

2 Business details

3 Contact information

Country

*

*

First name*

First name (phonetic)

*

Last name*

Last name (phonetic)

Salutation

Academic title

*

Email address*

Business phone

*

Company*

Job title

Industry

*

Function

*

Specialty

*

Department

*

State or Province

City

Address

Zip or Postal Code

By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.

Follow up information

*

Preferred method of contact

Best time to call

Estimated time of purchase

*

Comments

What is cross border data transfer?

I agree on cross-border transfer of personal information.

I agree on cross-border transfer of personal information.

CEE specific legal checkbox

CEE specific legal checkbox

CEE specific legal checkbox

CEE specific legal checkbox

I would like to receive marketing related electronic communications about Philips products, services, events and promotions that may be relevant to me based on my user preferences and behaviour.

I would like to receive marketing related electronic communications about Philips products, services, events and promotions that may be relevant to me based on my user preferences and behaviour.

What does this mean?

Final CEE consent
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
I understand

1. Davies JE, et al., Use of the Instantaneous Wave-free Ration or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834.
2. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.
3. Witzen B et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study. Circulation 2014 Jan: 129,4;463-470.
*Co-registration tools available within IntraSight 7 configuration via SyncVision

IntraSight

Interventional applications platform

Contact us

Contact information

Related products

Eagle Eye Platinum

Verrata Plus

Eagle Eye Platinum ST

SyncVision